Safety and efficacy of nivolumab plus ipilimumab (NIVO+IPI) in patients with advanced renal cell carcinoma (aRCC) with brain metastases: Interim analysis of CheckMate 920.
暂无分享，去创建一个
J. Bendell | D. Cho | D. George | A. Drakaki | A. Molina | S. Tykodi | Thomas E. Hutson | H. Emamekhoo | B. Carthon | I. Percent | L. Gordan | A. R. Kalebasty | M. Olsen | Tina C. Young | J. Johansen | Richard Lee